Search

Search Constraints

You searched for: Author/Creator Finetti, Pascal

Search Results

11. Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. Issue 1 (10th January 2022)

12. Ketogenic HMG‐CoA lyase and its product β‐hydroxybutyrate promote pancreatic cancer progression. (21st March 2022)

13. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Issue 10 (27th August 2021)

14. Low cholesterol biosynthesis favors epithelial‐to‐mesenchymal transition maintenance and influences tumor molecular subtyping and disease‐free survival in colon cancer patients. Issue 8 (30th June 2022)

16. Mevalonate Metabolism Regulates Basal Breast Cancer Stem Cells and Is a Potential Therapeutic Target123. (18th June 2012)

17. NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non‐inflammatory breast cancers. Issue 3 (5th February 2020)

18. Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response. Issue 1 (5th May 2020)

19. PARP1 expression in soft tissue sarcomas is a poor‐prognosis factor and a new potential therapeutic target. Issue 7 (7th June 2019)